Prevalence of functional GI disorders among pediatric patients with persistent asthma

Ruben J Colman1, Neal Bryan S Rosario2, Analydia Gutierrez Bonilla1

  • 1Department of Pediatrics, SBH Health System, Bronx, New York, USA.

Insights

Functional gastrointestinal disorders (FGIDs) are common in children with asthma, often linked to poor asthma control and anxiety. Early FGID screening in pediatric asthma patients is recommended.

Area of Science:

  • Pediatric Gastroenterology
  • Pediatric Pulmonology
  • Clinical Psychology

Background:

  • Functional gastrointestinal disorders (FGIDs) are prevalent in children, causing chronic gastrointestinal symptoms.
  • Previous research indicates a significant overlap between FGID and asthma.
  • Understanding this comorbidity is crucial for comprehensive pediatric care.

Purpose of the Study:

  • To determine the prevalence of FGID in pediatric patients diagnosed with persistent asthma.
  • To investigate the association between FGID and asthma control.
  • To explore the role of anxiety in FGID among asthmatic children.

Main Methods:

  • A prospective, cross-sectional study involving 110 pediatric patients with persistent asthma.
  • Utilized the pediatric ROME III questionnaire for FGID assessment.
  • Employed the Asthma Control Test and Beck Anxiety Inventory to measure asthma control and anxiety symptoms, respectively.

Main Results:

  • 16.4% of pediatric asthma patients met FGID criteria, with functional abdominal pain disorder being most common.
  • FGID patients exhibited significantly poorer asthma control (lower scores) and higher anxiety levels.
  • While asthma control initially predicted FGID, this association diminished after adjusting for anxiety.

Conclusions:

  • Functional gastrointestinal disorders are highly prevalent in children with persistent asthma.
  • FGID in pediatric asthma patients is associated with diminished asthma control and elevated anxiety.
  • Clinicians should consider FGID screening in pediatric asthma patients with poor control and assess for comorbid anxiety.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K